Action of probucol in arteries from normal and hypercholesterolaemic rabbits

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1639-1644

  Del Rio, M ^a   Chulia, T ^a   Ruiz, E ^a   Tejerina, T ^a  

^a SCHOOL OF MEDICINE   (Spain)

Author keywords

Atherosclerosis; Probucol; Rabbit arteries

Indexed keywords

CALCIUM ION; CHOLESTEROL; NORADRENALIN; POTASSIUM CHLORIDE; PROBUCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMORAL ARTERY; HYPERCHOLESTEROLEMIA; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR SMOOTH MUSCLE;

EID: 0029956927     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15586.x     Document Type: Article

References (40)

1. ABDALLA, S., ZARGA, M.A., AFIFI, F., AL-KHALIL, S., MAHASNEH, A. & SABRI, S. (1989). Effects of 3,3′-di-0-methylquercetin on guinea-pig isolated smooth muscle. J. Pharm. Pharmacol., 41, 138-141.
2. ATKINSON, J. (1992). Vascular calcium overload Physiological and pharmacological consequences. Drugs, 44 (1p), 11-118.
3. 2+ movements and contractile responses of rat aorta and its relevance to the action of Syntocinon. J. Pharm. Pharmacol., 36, 521-527.
4. BLUMLEIN, S.L., SIEVERS, R., KIDD, P. & PARMLEY, W.W. (1984). Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbits. Am. J. Cardiol., 54, 884-889.
5. BOLTON, T. (1979). Mechanism of action of transmitters and other substances on smooth muscle. Physiol. Rev., 59, 606.
6. CAUVIN, C., LOUTZENHISER, R. & VAN BREEMEN, C. (1983). Mechanism of calcium antagonists-induced vasodilation. Annu. Rev. Pharmacol. Toxicol., 23, 373-378.
7. CAUVIN, C., SAIDA, K. & VAN BREEMEN, C. (1982). Mechanism of calcium antagonist on Ca fluxes in resistance vessels. J. Cardiovasc. Pharmacol. Toxicol., 23, 373-277.
8. CAUVIN, C., TEJERINA, T. & VAN BREEMEN, C. (1987). Effects of atriopeptin III on isolated mesenteric resistance vessels from SHR and WKY. Am. J. Physiol., 253, H1612-1617.
9. DAUGHERTY, A., ZWEIFEL, B.S. & SCHOFELD, G. (1989). Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br. J. Pharmacol., 98, 612-618.
10. DOLE, V.P. (1956). A relationship between unesterified fatty acid in plasma and metabolism of glucose. J. Clin. Invest., 35, 150-154.
11. FLECKENSTEIN, A., FREY, M., THIMM. F. & FLECKENSTEINGRÜN, G. (1990). Excessive mural calcium overload. A predominant causal factor in the development of stenosing coronary plaques in humans. Cardiovasc. Drugs Ther., 4, 1006-1014.
12. GINSBURG, R., DAVIS, K., BRISTOW, M. et al. (1983). Calcium antagonists suppress atherogenesis in aorta but not in intramural coronary arteries of cholesterol-fed rabbits. Lab. Invest., 49, 154-158.
13. GODFRAIND, T. & KABA, A. (1969). Blockade or reversal of the contraction induced by calcium or adrenaline in depolarized arterial smooth muscle. Br. J. Pharmacol., 36, 548-560.
14. HEISTAD, D., ARMSTRONG, M.L., MARCUS, M.L., PIEGORS, D.J. & MARK, A.L. (1984). Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ. Res., 54, 711-718.
15. HENRY, P.D. (1990). Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature, 344, 160-162.
16. HUDGINS, P. & WEISS, G. (1968). Differential effects of calcium removal upon vascular smooth contraction induced by norepinephrine, histamine and potassium. J. Pharmacol. Exp. Ther., 159, 91-96.
17. KEANEY, J.F. Jr., XU, A., CUNNINGHAM, D., JACKSON, T., FREI, B. & VITA, J.A. (1995). Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide. J. Clin. Invest., 95, 2520-2529.
18. KHALIL, R., LODGE, R., SAIDA, K. & VAN BREEMEN, C. (1987). Mechanism of calcium activation in vascular smooth muscle. J. Hypertens., 5 (suppl. 4), S5.
19. KOLODGIE, F.D., VIRMANI, R., RICE, E.H. & MERGNER, W.J. (1990). Vascular reactivity during the progression of atherosclerotic plaque. Circ. Res., 66, 1112-1126.
20. 2+ currents independently of lipoxygenase inhibition. Mol. Pharmacol., 38, 524-530.
21. KUGIYAMA, K., KERNS, S.A., MORRISETT, J.D., ROBERTS, R., HENRY, P.D. (1990). Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature, 344, 160-2.
22. LEIJTEN, P. & VAN BREEMEN, C. (1984). The effect of caffeine on the noradrenaline-sensitive calcium store in rabbit aorta. J. Physiol., 357, 327-339.
23. LICHTLEN, O., HUGENHOLTZ, P., RAFFLENBLEUL, W., HECKER, H.J., OST, S. & DECKERS, J. W. (1990). Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Atherosclerotic Therapy (INTACT). Lancet, 335, 1109-1113.
24. MEISHERI, K., HWANG, O. & VAN BREEMEN, C. (1981). Evidence for two separate Ca entry pathways in smooth muscle plasmalemma. J. Membr. Biol., 59, 19-25.
25. PARTHASARATHY, S., YOUNG, S.G., WITZTUN, J.L., PITTMAN, R.C. & STEINBERG, D. (1986). Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest., 77, 641-644.
26. PFEUFFER, M.A., RICHARD, B.M. & PITTMAN, R. C. (1992). Probucol increases the selective uptake of HDL cholesterol esters by Hep G2 human hepatoma cells. Arterioscler. Thromb., 12, 870-878.
27. PLANE, F., JACOBS, M., McMANUS, D. & BRUCKDORFER, K.R. (1993). Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins. Atherosclerosis, 103, 73-79.
28. SASO, Y., KITAMURA, K., YASOSHIMA, A., IWASAKI, H.O., TAKASHIMA, K., DOI, K. & MORITA, T. (1992). Rapid induction of atherosclerosis in rabbits. Histol. Histopathol., 7, 315-330.
29. SGARAGLI, G.P., VALOTI, M., GORELLI, B., FUSI, F., PALMI, M. & MANTOVANI, P. (1993). Calcium antagonist and antiperoxidant properties of some hindered phenols. Br. J. Pharmacol., 110, 369-377.
30. SIGURDSSON, S., UVELINS, P. & JOHANSSON, B. (1975). Relative contribution of superficially bound and extracellular calcium to activation of contraction in isolated rat portal vein. Acta Physiol. Scand., 95, 263-267.
31. SIMON, B., HAUDENSCHILD, C. & COHEN, R. (1993). Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J. Cardiovasc. Pharmacol., 21, 893-901.
32. STARY, H.C. (1990). The sequence of cell and matrix changes in atherosclerosis lesions of coronary arteries in the first forty years of life. Eur. Heart J., 11 (suppl E), 3-19.
33. STEINBERG, D. (1986). Studies on the mechanism of action of probucol. Am. J. Cardiol., 57, 16H-21H.
34. STEINBERG, D., PARTHASARATY, S., CAREW, T.E., KHOO, J.C. & WITZTUM, J.L. (1989). Beyond cholesterol: modifications of low-density lipoproteins that increased its atherogenicity. N. Engl. J. Med., 320, 915-924.
35. STEINBERG, D. & WITZTUM, J.L. (1990). Review: Lipoproteins and atherogenesis: current concepts. J. Am. Med. Assoc., 264, 3047-3052.
36. TEJERINA, T., CAUVIN, C. & TAMARGO, T. (1992). Effects of oxodipine on isolated rabbit aorta and mesenteric resistance vessels. Eur. J. Pharmacol., 219, 279-284.
37. 2+ movements in the isolated rabbit aorta. Eur. J. Pharmacol., 148, 239-246.
38. 2+ movements in rat isolated aorta. J. Pharm. Pharmacol., 43, 46-48.
39. VAN HINSBERG, V.W.M. (1984). LDL cytotoxicity: the state of the art. Atherosclerosis, 53, 113-118.
40. WATANABE, N., ISHIKAWA, Y., OKAMOTO, R., WATANABE, Y. & FUKUZAKI, H. (1987). Nifedipine suppresses atherosclerosis in cholesterol-fed rabbits but not Watanabe heritable hyperlipidemic rabbits. Artery, 14, 283-294.